Article
alloHCT With Reduced Intensity Conditioning Shown Safe in Myeloma Despite Low Accrual Leading to Early Trial Termination
Rating:
0.0
Views:
81
Likes:
1
Library:
1
Allogeneic hematopoietic cell transplantation was shown to be safe when performed with a reduced-intensity conditioning regimen of bortezomib, fludarabine, and melphalan in patients with high-risk multiple myeloma
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value